CSL LimitedASX: CSL

Vifor update ASX Announcement for lodgement

· Issued by CSL Limited

Filed with ASX · · 1 page · English

CSL Limited (ASX: CSL; USOTC:CSLLY) has previously advised that it expected to be in a position to close the acquisition of Vifor Pharma AG by June 2022. CSL now expects the regulatory approval process to take a few more months. CSL remains confident of completing its acquisition of Vifor Pharma AG and looks forward to expanding its presence in the rapidly growing nephrology market, as well as lev

CSL Limited on 6ix

Earlier from CSL

Later from CSL

All CSL news releases